Results     16-May-13
Announcements
Orchid Chemicals & Pharmaceuticals reports net loss of Rs 132.27 crore in the March 2013 quarter
Sales decline 40.66% to Rs 268.16 crore
Net loss of Orchid Chemicals & Pharmaceuticals reported to Rs 132.27 crore in the quarter ended March 2013 as against net profit of Rs 20.55 crore during the previous quarter ended March 2012. Sales declined 40.66% to Rs 268.16 crore in the quarter ended March 2013 as against Rs 451.92 crore during the previous quarter ended March 2012.

For the Audited full year,net loss reported to Rs 275.37 crore in the year ended March 2013 as against net profit of Rs 103.11 crore during the previous year ended March 2012. Sales declined 27.84% to Rs 1227.87 crore in the year ended March 2013 as against Rs 1701.71 crore during the previous year ended March 2012.

ParticularsQuarter EndedYear Ended
 Mar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.
Sales268.16451.92 -41 1227.871701.71 -28
OPM %5.2121.81 -76 10.8024.19 -55
PBDT-71.7930.72 PL -171.66232.68 PL
PBT-110.42-9.69 -1040 -328.8283.62 PL
NP-132.2720.55 PL -275.37103.11 PL

Previous News
  Orchid Pharma reports consolidated net loss of Rs 15.01 crore in the June 2022 quarter
 ( Results - Announcements 11-Aug-22   08:49 )
  Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
 ( Hot Pursuit - 29-Jun-24   10:08 )
  Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
 ( Corporate News - 28-Jun-24   19:23 )
  Board of Orchid Pharma approves draft scheme of amalgamation and arrangement
 ( Corporate News - 17-Dec-21   10:19 )
  Orchid Pharma reports standalone net loss of Rs 26.02 crore in the June 2021 quarter
 ( Results - Announcements 14-Aug-21   07:57 )
  Orchid Pharma to table results
 ( Corporate News - 04-May-23   11:36 )
  Orchid Pharma reports standalone net loss of Rs 54.31 crore in the March 2020 quarter
 ( Results - Announcements 30-Jun-20   12:44 )
  Orchid Pharma to discuss results
 ( Corporate News - 08-Nov-22   16:53 )
  Orchid Pharma reports consolidated net profit of Rs 9.40 crore in the June 2023 quarter
 ( Results - Announcements 12-Aug-23   12:13 )
  Orchid Pharma receives ANDA approval for Risedronate Sodium Tablets
 ( Corporate News - 14-May-19   16:55 )
  Orchid Pharma reports standalone net loss of Rs 13.45 crore in the March 2019 quarter
 ( Results - Announcements 04-Jun-19   17:13 )
Other Stories
  Atlas Cycles (Haryana) reports standalone net loss of Rs 0.46 crore in the June 2024 quarter
  06-Jul-24   07:32
  Emerald Finance consolidated net profit rises 98.84% in the June 2024 quarter
  05-Jul-24   15:52
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
Back Top